These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 24361249)

  • 1. Association between race and survival of patients with non--small-cell lung cancer in the United States veterans affairs population.
    Ganti AK; Subbiah SP; Kessinger A; Gonsalves WI; Silberstein PT; Loberiza FR
    Clin Lung Cancer; 2014 Mar; 15(2):152-8. PubMed ID: 24361249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How do social factors explain outcomes in non-small-cell lung cancer among Hispanics in California? Explaining the Hispanic paradox.
    Patel MI; Schupp CW; Gomez SL; Chang ET; Wakelee HA
    J Clin Oncol; 2013 Oct; 31(28):3572-8. PubMed ID: 23960183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Japanese ethnicity compared with Caucasian ethnicity and never-smoking status are independent favorable prognostic factors for overall survival in non-small cell lung cancer: a collaborative epidemiologic study of the National Hospital Organization Study Group for Lung Cancer (NHSGLC) in Japan and a Southern California Regional Cancer Registry databases.
    Kawaguchi T; Matsumura A; Fukai S; Tamura A; Saito R; Zell JA; Maruyama Y; Ziogas A; Kawahara M; Ignatius Ou SH
    J Thorac Oncol; 2010 Jul; 5(7):1001-10. PubMed ID: 20526205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unlimited access to care: effect on racial disparity and prognostic factors in lung cancer.
    Mulligan CR; Meram AD; Proctor CD; Wu H; Zhu K; Marrogi AJ
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):25-31. PubMed ID: 16434582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial Differences in Treatment and Survival among Veterans and Non-Veterans with Stage I NSCLC: An Evaluation of Veterans Affairs and SEER-Medicare Populations.
    Williams CD; Alpert N; Redding TS; Bullard AJ; Flores RM; Kelley MJ; Taioli E
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):112-118. PubMed ID: 31624076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparate outcomes in nonsmall cell lung cancer by immigration status.
    Chau B; Ituarte PH; Shinde A; Li R; Vazquez J; Glaser S; Massarelli E; Salgia R; Erhunmwunsee L; Ashing K; Amini A
    Cancer Med; 2021 Apr; 10(8):2660-2667. PubMed ID: 33734614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
    Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
    J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next Generation Sequencing of Advanced Non-Small Cell Lung Cancer: Utilization Based on Race and Impact on Survival.
    Al-Ahmadi A; Ardeshir-Larijani F; Fu P; Cao S; Lipka MB; Dowlati A; Bruno DS
    Clin Lung Cancer; 2021 Jan; 22(1):16-22.e1. PubMed ID: 33397584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of race in lung cancer: analysis of temporal trends from a surveillance, epidemiology, and end results database.
    Gadgeel SM; Severson RK; Kau Y; Graff J; Weiss LK; Kalemkerian GP
    Chest; 2001 Jul; 120(1):55-63. PubMed ID: 11451816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.
    Koshy M; Fedewa SA; Malik R; Ferguson MK; Vigneswaran WT; Feldman L; Howard A; Abdelhady K; Weichselbaum RR; Virgo KS
    J Thorac Oncol; 2013 Jul; 8(7):915-22. PubMed ID: 23608815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cox Regression and Parametric Models: Comparison of How They Determine Factors Influencing Survival of Patients with Non-Small Cell Lung Carcinoma.
    Khaksar E; Askarishahi M; Hekmatimoghaddam S; Vahedian-Ardakani H
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3389-3393. PubMed ID: 29286608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Staging With Positron-emission Tomography (PET) and Comorbidities on Management and Survival of American Veterans With Stage I-III Non-Small Cell Lung Cancer.
    Raghunathan R; Cease K; Troeschel S; Zhao L; Gross M; Chen G; Chopra V; Ramnath N
    Am J Clin Oncol; 2018 May; 41(5):513-518. PubMed ID: 27322696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice.
    Faehling M; Schwenk B; Kramberg S; Fallscheer S; Leschke M; Sträter J; Eckert R
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):2059-2066. PubMed ID: 30062488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External Validation of a Survival Nomogram for Non-Small Cell Lung Cancer Using the National Cancer Database.
    Young KA; Efiong E; Dove JT; Blansfield JA; Hunsinger MA; Wild JL; Shabahang MM; Facktor MA
    Ann Surg Oncol; 2017 Jun; 24(6):1459-1464. PubMed ID: 28168388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
    Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
    J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer.
    Gao SJ; Corso CD; Wang EH; Blasberg JD; Detterbeck FC; Boffa DJ; Decker RH; Kim AW
    J Thorac Oncol; 2017 Feb; 12(2):314-322. PubMed ID: 27720827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Care and Outcomes of Older Persons with Lung Cancer in England and the United States, 2008-2012.
    Andreano A; Peake MD; Janes SM; Valsecchi MG; Pritchard-Jones K; Hoag JR; Gross CP
    J Thorac Oncol; 2018 Jul; 13(7):904-914. PubMed ID: 29727739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Elderly Patients Who Receive Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer.
    Zaki M; Dominello M; Dyson G; Gadgeel S; Wozniak A; Miller S; Paximadis P
    Clin Lung Cancer; 2017 Jan; 18(1):e21-e26. PubMed ID: 27567356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of comorbidity on racial differences in receipt of surgery among US veterans with early-stage non-small-cell lung cancer.
    Williams CD; Stechuchak KM; Zullig LL; Provenzale D; Kelley MJ
    J Clin Oncol; 2013 Feb; 31(4):475-81. PubMed ID: 23269988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.